Plymouth Meeting, PA, United States of America

Mike McLane


Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • Plymouth Meeting, PA (US) (2003 - 2008)
  • Lansdale, PA (US) (2004 - 2009)

Company Filing History:


Years Active: 2003-2009

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Mike McLane

Introduction

Mike McLane, an innovative inventor based in Plymouth Meeting, PA, holds a notable portfolio of six patents. His work primarily focuses on the development of therapeutic applications aimed at addressing various respiratory diseases. McLane's inventive contributions continue to make significant impacts in the field of medicine, particularly in the modulation of mucin synthesis.

Latest Patents

Two of Mike McLane's latest patents revolve around mucin synthesis inhibitors. The inventions relate to methods of regulating mucin synthesis and the therapeutic applications of compounds that can help control mucin over-production. This over-production is often associated with chronic obstructive pulmonary diseases (COPD), including asthma and chronic bronchitis, as well as inflammatory lung diseases like cystic fibrosis and acute or chronic respiratory infectious diseases. These patents showcase his commitment to addressing pressing health challenges through innovative solutions.

Career Highlights

Mike McLane has made remarkable strides in his career as an inventor, primarily through his work at Genaera Corporation. His expertise in developing therapeutic methods has solidified his position as a key player in the field of biomedical innovation. McLane's contributions have not only resulted in significant patents but have also paved the way for potential new treatments that can enhance the quality of life for individuals suffering from respiratory conditions.

Collaborations

Throughout his career, Mike has collaborated with esteemed colleagues, including Yuhong Zhou and Roy Clifford Levitt. These partnerships have been instrumental in advancing his research and fostering innovative solutions in the realm of mucin synthesis and its implications for health.

Conclusion

In summary, Mike McLane stands out as a dedicated inventor whose work is crucial in combating significant health issues related to mucin over-production. His latest patents reflect his innovative spirit and commitment to improving therapeutic approaches for respiratory diseases. As he continues to collaborate and innovate at Genaera Corporation, the medical community eagerly anticipates the positive impacts of his inventions on public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…